Release of CXCL12 From Apoptotic Skeletal Cells Contributes to Bone Growth Defects Following Dexamethasone Therapy in Rats

Journal of Bone and Mineral Research - United States
doi 10.1002/jbmr.3597
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Bone Growth During Rapamycin Therapy in Young Rats

BMC Pediatrics
Child HealthPediatricsPerinatology
2009English

Matrix Metalloproteinase-9 From Bone Marrow–Derived Cells Contributes to Survival but Not Growth of Tumor Cells in the Lung Microenvironment

Cancer Research
Cancer ResearchOncology
2006English

Tissue Constructs With Human Adipose-Derived Mesenchymal Stem Cells to Treat Bone Defects in Rats

Materials
Materials ScienceCondensed Matter Physics
2019English

Somatic Innervation Contributes to the Release of Bulbourethral Gland Secretion in Male Rats

Andrology
EndocrinologyReproductive MedicineUrologyMetabolismDiabetes
2018English

Histone Hypoacetylation Contributes to CXCL12 Downregulation in Colon Cancer : Impact on Tumor Growth and Cell Migration

Oncotarget
Oncology
2017English

Fibrin Biopolymer as Scaffold Candidate to Treat Bone Defects in Rats

Journal of Venomous Animals and Toxins Including Tropical Diseases
Animal ScienceZoologyParasitologyInfectious DiseasesToxicology
2019English

Dosing-Time Dependent Effect of Dexamethasone on Bone Density in Rats

Life Sciences
GeneticsMolecular BiologyPharmacologyBiochemistryMedicineToxicologyPharmaceutics
2010English

Controlled Release of Clarithromycin From PLGA Microspheres Enhances Bone Regeneration in Rabbit Calvaria Defects

Journal of Biomedical Materials Research - Part B Applied Biomaterials
Biomedical EngineeringBiomaterials
2017English

The Presence of Apoptotic Bone Marrow Cells Impairs the Efficacy of Cardiac Cell Therapy

Cell Transplantation
TransplantationBiomedical EngineeringCell Biology
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy